TNF and rheumatoid arthritis: This finding is in contrast with data from other registries on RA patients in combination therapy [34, 35], showing that drug survival in switchers was lower than in anti-TNF naïves [34, 36] and an increased risk of withdrawing from the second treatment for the same reason as the first, regardless of whether it was due to inefficacy or adverse events [35].